Clinical Trial Update: To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and PK-PD relationship of KD101 when taken in the fed state in obese or o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• KD101

Snippet

Sponsor: Kwang Dong Pharmaceutical co., ltd. | Conditions: Obesity | Phase 1 | Status: UNKNOWN